Pathophysiology of mitochondrial volume homeostasis: Potassium transport and permeability transition

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1787, Issue 5, 2009, Pages 345-350

  Nowikovsky, Karin ^a   Schweyen, Rudolf J ^a   Bernardi, Paolo ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cyclosporin A; Mitochondria; Permeability transition; Potassium transport; Volume homeostasis

Indexed keywords

MITOCHONDRIAL PROTEIN; POTASSIUM; POTASSIUM ION; PROTON;

CATION TRANSPORT; ELECTROPHORESIS; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; ION TRANSPORT; MEMBRANE PERMEABILITY; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; PATHOPHYSIOLOGY; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL TRANSPORT; CELL MEMBRANE PERMEABILITY; HOMEOSTASIS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL SWELLING; MUSCULAR DYSTROPHIES; PERMEABILITY; POTASSIUM; POTASSIUM CHANNELS; POTASSIUM-HYDROGEN ANTIPORTERS; REACTIVE OXYGEN SPECIES; WOLF-HIRSCHHORN SYNDROME;

EID: 67349113204     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2008.10.006     Document Type: Review

References (82)

1. Mitchell P. Chemiosmotic Coupling in Oxidative and Photosynthetic Phosphorylation, Glynn Research (1966), Bodmin (Cornwall), England
2. Mitchell P. Keilin's respiratory chain concept and its chemiosmotic consequences. Science 206 (1979) 1148-1159
3. Hunter D.R., Haworth R.A., and Southard J.H. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J. Biol. Chem. 251 (1976) 5069-5077
4. Bernardi P. Mitochondrial transport of cations: channels, exchangers and permeability transition. Physiol. Rev. 79 (1999) 1127-1155
5. Cereghetti G.M., and Scorrano L. The many shapes of mitochondrial death. Oncogene 25 (2006) 4717-4724
6. Azzone G.F., and Azzi A. Volume changes in liver mitochondria. Proc. Natl. Acad. Sci. U. S. A. 53 (1965) 1084-1089
7. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J. Biol. Chem. 267 (1992) 8834-8839
8. Bernardi P., and Azzone G.F. Cytochrome c as an electron shuttle between the outer and inner mitochondrial membranes. J. Biol. Chem. 256 (1981) 7187-7192
9. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., and Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15 (1995) 961-973
10. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86 (1996) 147-157
11. + conductance of the inner mitochondrial membrane. A study of the inducible uniport for monovalent cations. J. Biol. Chem. 266 (1991) 9465-9470
12. + electrochemical gradient in rat-liver mitochondria. Eur. J. Biochem. 126 (1982) 443-451
13. + uniport in mitochondria treated with the ionophore A23187. J. Biol. Chem. 264 (1989) 18902-18906
14. 2+. Eur. J. Biochem. 188 (1990) 91-97
15. + uniports induced by magnesium removal. J. Biol. Chem. 265 (1990) 18063-18066
16. Kirichok Y., Krapivinsky G., and Clapham D.E. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427 (2004) 360-364
17. + channel in the mitochondrial inner membrane. Nature 352 (1991) 244-247
18. Grover G.J., and Garlid K.D. ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J. Mol. Cell Cardiol. 32 (2000) 677-695
19. Szabó I., Bock J., Jekle A., Soddemann M., Adams C., Lang F., Zoratti M., and Gulbins E. A novel potassium channel in lymphocyte mitochondria. J. Biol. Chem. 280 (2005) 12790-12798
20. + channel in macrophages. J. Biol. Chem. 281 (2006) 37675-37685
21. Szabó I., Bock J., Grassmé H., Soddemann M., Wilker B., Lang F., Zoratti M., and Gulbins E. Mitochondrial potassium channel Kv1.3 mediates Bax induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. USA 105 (2008) 14861-14866
22. 2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem. Biophys. Res. Commun. 257 (1999) 549-554
23. Douglas R.M., Lai J.C., Bian S., Cummins L., Moczydlowski E., and Haddad G.G. The calcium-sensitive large-conductance potassium channel (BK/MAXI K) is present in the inner mitochondrial membrane of rat brain. Neuroscience 139 (2006) 1249-1261
24. Kulawiak B., Kudin A.P., Szewczyk A., and Kunz W.S. BK channel openers inhibit ROS production of isolated rat brain mitochondria. Exp. Neurol. 212 (2008) 543-547
25. 2+-activated potassium channel beta4 subunit in rat brain: immunolocalization in neuronal mitochondria. Neuroscience 153 (2008) 446-460
26. Skalska J., Piwonska M., Wyroba E., Surmacz L., Wieczorek R., Koszela-Piotrowska I., Zielinska J., Bednarczyk P., Dolowy K., Wilczynski G.M., Szewczyk A., and Kunz W.S. A novel potassium channel in skeletal muscle mitochondria. Biochim. Biophys. Acta (2008) 10.1016/j.bbabio.2008.05.007
27. + channels in the cardiac inner mitochondrial membrane. Science 298 (2002) 1029-1033
28. Gu X.Q., Siemen D., Parvez S., Cheng Y., Xue J., Zhou D., Sun X., Jonas E.A., and Haddad G.G. Hypoxia increases BK channel activity in the inner mitochondrial membrane. Biochem. Biophys. Res. Commun. 358 (2007) 311-316
29. Rusznak Z., Bakondi G., Kosztka L., Pocsai K., Dienes B., Fodor J., Telek A., Gonczi M., Szucs G., and Csernoch L. Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells. Virchows Arch. 452 (2008) 415-426
30. + antiport in rat liver mitochondria. J. Biol. Chem. 259 (1984) 2062-2065
31. + antiporter from rat liver mitochondria. J. Biol. Chem. 265 (1990) 15316-15322
32. + homeostasis with a potential role in the Wolf-Hirschhorn Syndrome. J. Biol. Chem. 279 (2004) 30307-30315
33. + exchange in mitochondrial membrane vesicles involves Yol027/Letm1 proteins. Biochim. Biophys. Acta 1711 (2005) 41-48
34. + exchange activity, osmotic swelling and mitophagy. Cell Death Differ. 14 (2007) 1647-1656
35. Dimmer K.S., Navoni F., Casarin A., Trevisson E., Endele S., Winterpacht A., Salviati L., and Scorrano L. LETM1, deleted in Wolf Hirschhorn syndrome is required for normal mitochondrial morphology and cellular viability. Hum. Mol. Genet. 17 (2008) 201-214
36. Hasegawa A., and van der Bliek A.M. Inverse correlation between expression of the Wolfs Hirschhorn candidate gene Letm1 and mitochondrial volume in C. elegans and in mammalian cells. Hum. Mol. Genet. 16 (2007) 2061-2071
37. Wolf U., Porsch R., Baitsch H., and Reinwein H. Deletion on short arms of a B-chromosome without "Cri du Chat" Syndrome. Lancet 1 (1965) 769
38. Hirschhorn K., Cooper H.L., and Firschein I.L. Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik 1 (1965) 479-482
39. 2+-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients. Genomics 60 (1999) 218-225
40. Zollino M., Lecce R., Fischetto R., Murdolo M., Faravelli F., Selicorni A., Butte C., Memo L., Capovilla G., and Neri G. Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Am. J. Hum. Genet. 72 (2003) 590-597
41. Johnson V.P., Mulder R.D., and Hosen R. The Wolf-Hirschhorn (4p-) syndrome. Clin. Genet. 10 (1976) 104-112
42. Wilson M.G., Towner J.W., Coffin G.S., Ebbin A.J., Siris E., and Brager P. Genetic and clinical studies in 13 patients with the Wolf-Hirschhorn syndrome [del(4p)]. Hum. Genet. 59 (1981) 297-307
43. Zollino M., Di S.C., Zampino G., Mastroiacovo P., Wright T.J., Sorge G., Selicorni A., Tenconi R., Zappala A., Battaglia A., Di R.M., Palka G., Pallotta R., Altherr M.R., and Neri G. Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. Am. J. Med. Genet. 94 (2000) 254-261
44. Schlickum S., Moghekar A., Simpson J.C., Steglich C., O'Brien R.J., Winterpacht A., and Endele S.U. LETM1, a gene deleted in Wolf-Hirschhorn syndrome, encodes an evolutionarily conserved mitochondrial protein. Genomics 83 (2004) 254-261
45. DiMauro S., and Schon E.A. Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 31 (2008) 91-123
46. Kudin A.P., Debska-Vielhaber G., Vielhaber S., Elger C.E., and Kunz W.S. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45 (2004) 1478-1487
47. 2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys. 195 (1979) 453-459
48. 2+ trigger site. Arch. Biochem. Biophys. 195 (1979) 460-467
49. 2+ release. Arch. Biochem. Biophys. 195 (1979) 468-477
50. Bernardi P., Krauskopf A., Basso E., Petronilli V., Blachly-Dyson E., Di Lisa F., and Forte M.A. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 273 (2006) 2077-2099
51. Rasola A., and Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12 (2007) 815-833
52. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cai J., Jones D.P., MacGregor G.R., and Wallace D.C. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427 (2004) 461-465
53. Krauskopf A., Eriksson O., Craigen W.J., Forte M.A., and Bernardi P. Properties of the permeability transition in VDAC1-/- mitochondria. Biochim. Biophys. Acta Bioenergetics 1757 (2006) 590-595
54. Baines C.P., Kaiser R.A., Sheiko T., Craigen W.J., and Molkentin J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9 (2007) 550-555
55. Forte M., and Bernardi P. Genetic dissection of the permeability transition pore. J. Bioenerg. Biomembr. 37 (2005) 121-128
56. 2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J. 268 (1990) 153-160
57. Fournier N., Ducet G., and Crevat A. Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr. 19 (1987) 297-303
58. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255 (1988) 357-360
59. Broekemeier K.M., Dempsey M.E., and Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264 (1989) 7826-7830
60. Nicolli A., Basso E., Petronilli V., Wenger R.M., and Bernardi P. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J. Biol. Chem. 271 (1996) 2185-2192
61. Waldmeier P.C., Feldtrauer J.J., Qian T., and Lemasters J.J. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol. Pharmacol. 62 (2002) 22-29
62. Hansson M.J., Mattiasson G., Mansson R., Karlsson J., Keep M.F., Waldmeier P., Ruegg U.T., Dumont J.M., Besseghir K., and Elmer E. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J. Bioenerg. Biomembr. 36 (2004) 407-413
63. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., Elbelghiti R., Cung T.T., Bonnefoy E., Angoulvant D., Macia C., Raczka F., Sportouch C., Gahide G., Finet G., André-Fouët X., Revel D., Kirkorian G., Monassier J.-P., Derumeaux G., and Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. New Engl. J. Med. 359 (2008) 473-481
64. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., and Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
65. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., and Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 280 (2005) 18558-18561
66. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., and Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434 (2005) 652-658
67. Schinzel A.C., Takeuchi O., Huang Z., Fisher J.K., Zhou Z., Rubens J., Hetz C., Danial N.N., Moskowitz M.A., and Korsmeyer S.J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12005-12010
68. Forte M., Gold B.G., Marracci G., Chaudhary P., Basso E., Johnsen D., Yu X., Fowlkes J., Rahder M., Stem K., Bernardi P., and Bourdette D. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 7558-7563
69. Bonaldo P., Braghetta P., Zanetti M., Piccolo S., Volpin D., and Bressan G.M. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum. Mol. Genet. 7 (1998) 2135-2140
70. Irwin W.A., Bergamin N., Sabatelli P., Reggiani C., Megighian A., Merlini L., Braghetta P., Columbaro M., Volpin D., Bressan G.M., Bernardi P., and Bonaldo P. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat. Genet. 35 (2003) 267-271
71. Angelin A., Tiepolo T., Sabatelli P., Grumati P., Bergamin N., Golfieri C., Mattioli E., Gualandi F., Ferlini A., Merlini L., Maraldi N.M., Bonaldo P., and Bernardi P. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 991-996
72. Merlini L., Angelin A., Tiepolo T., Braghetta P., Sabatelli P., Zamparelli A., Ferlini A., Maraldi N.M., Bonaldo P., and Bernardi P. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 5225-5229
73. Angelin A., Bonaldo P., and Bernardi P. Altered threshold of the mitochondrial permeability transition pore in Ullrich congenital muscular dystrophy. Biochim. Biophys. Acta Bioenerg. 1777 (2008) 893-896
74. Millay D.P., Sargent M.A., Osinska H., Baines C.P., Barton E.R., Vuagniaux G., Sweeney H.L., Robbins J., and Molkentin J.D. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med. 14 (2008) 442-447
75. Reutenauer J., Dorchies O.M., Patthey-Vuadens O., Vuagniaux G., and Ruegg U.T. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br. J. Pharmacol. 155 (2008) 574-584
76. Bonuccelli G., Sotgia F., Schubert W., Park D.S., Frank P.G., Woodman S.E., Insabato L., Cammer M., Minetti C., and Lisanti M.P. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am. J. Pathol. 163 (2003) 1663-1675
77. Scorrano L., Petronilli V., and Bernardi P. On the voltage dependence of the mitochondrial permeability transition pore. A critical appraisal. J. Biol. Chem. 272 (1997) 12295-12299
78. + channels. Circ. Res. 81 (1997) 1072-1082
79. + channels prevent oxidative stress, permeability transition and cell death. J. Bioenerg. Biomembr. 37 (2005) 75-82
80. 2 inhibit the permeability transition. J. Biol. Chem. 281 (2006) 20801-20808
81. Basso E., Petronilli V., Forte M.A., and Bernardi P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin a and by cyclophilin d ablation. J. Biol. Chem. 283 (2008) 26307-26311
82. Kim I., Rodriguez-Enriquez S., and Lemasters J.J. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462 (2007) 245-253